.Common-Size Income Statement
Difficulty: Beginner
Amgen Inc., Common-Size Consolidated Income Statement
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| | Product sales | ||||||||||
| | Cost of sales | ||||||||||
| | Gross profit from product sales | % | | % | | % | | % | | % | |
| | Other revenues | ||||||||||
| | Research and development | ||||||||||
| | Selling, general and administrative | ||||||||||
| | Other | ||||||||||
| | Operating income | % | | % | | % | | % | | % | |
| | Interest expense, net | ||||||||||
| | Interest and other income, net | ||||||||||
| | Income before income taxes | % | | % | | % | | % | | % | |
| | Provision for income taxes | ||||||||||
| | Net income | % | | % | | % | | % | | % | |
